125 related articles for article (PubMed ID: 17727910)
21. The region of the herpes simplex virus type 1 LAT gene involved in spontaneous reactivation does not encode a functional protein.
Drolet BS; Perng GC; Cohen J; Slanina SM; Yukht A; Nesburn AB; Wechsler SL
Virology; 1998 Mar; 242(1):221-32. PubMed ID: 9501054
[TBL] [Abstract][Full Text] [Related]
22. Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis.
Branco FJ; Fraser NW
J Virol; 2005 Jul; 79(14):9019-25. PubMed ID: 15994795
[TBL] [Abstract][Full Text] [Related]
23. Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts.
Margolis TP; Imai Y; Yang L; Vallas V; Krause PR
J Virol; 2007 Feb; 81(4):1872-8. PubMed ID: 17151134
[TBL] [Abstract][Full Text] [Related]
24. Herpes simplex virus type-1 latency inhibits dendritic growth in sympathetic neurons.
Hamza MA; Higgins DM; Ruyechan WT
Neurobiol Dis; 2006 Nov; 24(2):367-73. PubMed ID: 16952455
[TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus 1 blocks caspase-3-independent and caspase-dependent pathways to cell death.
Galvan V; Brandimarti R; Roizman B
J Virol; 1999 Apr; 73(4):3219-26. PubMed ID: 10074175
[TBL] [Abstract][Full Text] [Related]
26. Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter.
Kenny JJ; Krebs FC; Hartle HT; Gartner AE; Chatton B; Leiden JM; Hoeffler JP; Weber PC; Wigdahl B
Virology; 1994 Apr; 200(1):220-35. PubMed ID: 8128624
[TBL] [Abstract][Full Text] [Related]
27. Significantly increased expression of beta-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector.
Zhu J; Kang W; Wolfe JH; Fraser NW
Mol Ther; 2000 Jul; 2(1):82-94. PubMed ID: 10899831
[TBL] [Abstract][Full Text] [Related]
28. A herpes simplex virus type 1 mutant deleted for gamma34.5 and LAT kills glioma cells in vitro and is inhibited for in vivo reactivation.
Samoto K; Perng GC; Ehtesham M; Liu Y; Wechsler SL; Nesburn AB; Black KL; Yu JS
Cancer Gene Ther; 2001 Apr; 8(4):269-77. PubMed ID: 11393279
[TBL] [Abstract][Full Text] [Related]
29. Construction of a herpes simplex virus type 1 mutant with only a three-nucleotide change in the branchpoint region of the latency-associated transcript (LAT) and the stability of its two-kilobase LAT intron.
Ng AK; Block TM; Aiamkitsumrit B; Wang M; Clementi E; Wu TT; Taylor JM; Su YH
J Virol; 2004 Nov; 78(22):12097-106. PubMed ID: 15507596
[TBL] [Abstract][Full Text] [Related]
30. Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia.
Maggioncalda J; Mehta A; Su YH; Fraser NW; Block TM
Virology; 1996 Nov; 225(1):72-81. PubMed ID: 8918535
[TBL] [Abstract][Full Text] [Related]
31. The US3 protein kinase of herpes simplex virus 1 mediates the posttranslational modification of BAD and prevents BAD-induced programmed cell death in the absence of other viral proteins.
Munger J; Roizman B
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10410-5. PubMed ID: 11517326
[TBL] [Abstract][Full Text] [Related]
32. Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells.
Danaher RJ; Jacob RJ; Steiner MR; Allen WR; Hill JM; Miller CS
J Neurovirol; 2005 Jul; 11(3):306-17. PubMed ID: 16036811
[TBL] [Abstract][Full Text] [Related]
33. Induction of apoptosis by herpes simplex virus in Jurkat cells is partly through caspase-3, -8 and -9 activation.
Pongpanich A; Bhattarakosol P; Chirathaworn C
J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S140-5. PubMed ID: 16083178
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a spliced exon product of herpes simplex type-1 latency-associated transcript in productively infected cells.
Kang W; Mukerjee R; Gartner JJ; Hatzigeorgiou AG; Sandri-Goldin RM; Fraser NW
Virology; 2006 Dec 5-20; 356(1-2):106-14. PubMed ID: 16938324
[TBL] [Abstract][Full Text] [Related]
35. Herpes simplex virus UL14 protein blocks apoptosis.
Yamauchi Y; Daikoku T; Goshima F; Nishiyama Y
Microbiol Immunol; 2003; 47(9):685-9. PubMed ID: 14584616
[TBL] [Abstract][Full Text] [Related]
36. Herpes simplex virus-1 (HSV-1) infection induces a potent but ineffective IFN-λ production in immune cells of AD and PD patients.
La Rosa F; Agostini S; Bianchi A; Nemni R; Piancone F; Marventano I; Mancuso R; Saresella M; Clerici M
J Transl Med; 2019 Aug; 17(1):286. PubMed ID: 31455413
[TBL] [Abstract][Full Text] [Related]
37. Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer's Disease.
Harris SA; Harris EA
Front Aging Neurosci; 2018; 10():48. PubMed ID: 29559905
[TBL] [Abstract][Full Text] [Related]
38. Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan.
Tzeng NS; Chung CH; Lin FH; Chiang CP; Yeh CB; Huang SY; Lu RB; Chang HA; Kao YC; Yeh HW; Chiang WS; Chou YC; Tsao CH; Wu YF; Chien WC
Neurotherapeutics; 2018 Apr; 15(2):417-429. PubMed ID: 29488144
[TBL] [Abstract][Full Text] [Related]
39. Pseudorabies virus gM and its homologous proteins in herpesviruses induce mitochondria-related apoptosis involved in viral pathogenicity.
Zhou Q; Shi D; Tang YD; Zhang L; Hu B; Zheng C; Huang L; Weng C
PLoS Pathog; 2024 Apr; 20(4):e1012146. PubMed ID: 38669242
[TBL] [Abstract][Full Text] [Related]
40. Regulation of herpes simplex virus type 1 latency-reactivation cycle and ocular disease by cellular signaling pathways.
Harrison KS; Jones C
Exp Eye Res; 2022 May; 218():109017. PubMed ID: 35240194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
